Deslorelin treatment of hyperoestrogenism in neutered ferrets (Mustela putorius furo): A case report

A. Prohaczik, M. Kulcsár, G. Huszenicza

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Hyperoestrogenism causing progressive alopecia in neutered ferrets may be induced by ovarian remnant syndrome (ORS) and nodular hyperplasia of the adrenocortex (hyperadrenocorticism, NHA). The objective of the study was to determine whether a slow-release implant of a gonadotropin releasing hormone (GnRH) analogue, deslorelin, has any value in therapy of hyperoestrogenism of adrenocortical origin (NHA). Three supposed cases of NHA with alopecia and other clinical signs of hyperoestrogenism (n = 2 spayed females in oestrous and n = 1 castrated male) were treated with a subcutaneous implant of 4.7 mg deslorelin acetate. Blood samples were collected, and plasma levels of estradiol (E2) were determined just before, and some weeks after treatment. For realistic monitoring, blood samples for E2 determination were also taken from intact, healthy (untreated control) females after the beginning of heat (n = 5), or 9-21 days after, with hCG induced ovulation (n = 6), or out of breeding season (n = 3). Before treatment, all three alopecic ferrets showed elevated E2 concentrations (99.45-139.9 pmol/l) similar to the untreated control females in oestrous (61.6-123.02 pmol/l) (P = 0.229). Some weeks after the deslorelin administration, the hair of these ferrets began to grow again and the elevated E2 concentrations significantly decreased compared to the pre-treatment values (P = 0.035). E2 concentrations reached the basal level (12.89-16.08 pmol/l) typical for that of the untreated control females in anoestrus or in luteal phase (12.0-30.58 pmol/l) (P = 0.137). All treated ferrets were examined again 19-21 months after implant insertion (the implant still being present) and all of them had normal hair and were clinically healthy. These observations prove that deslorelin can suppress the E2 production of NHA, and is therefore a useful tool in the therapy of hormonal alopecia neutered ferrets.

Original languageEnglish
Pages (from-to)89-95
Number of pages7
JournalVeterinarni Medicina
Volume54
Issue number2
Publication statusPublished - Feb 2009

Fingerprint

Ferrets
ferrets
alopecia
case studies
Alopecia
Hair
hairs
Adrenocortical Hyperfunction
Anestrus
Therapeutics
synthetic hormones
hyperadrenocorticism
therapeutics
anestrus
Luteal Phase
human chorionic gonadotropin
blood
gonadotropin-releasing hormone
Ovulation
corpus luteum

Keywords

  • Deslorelin
  • Estradiol
  • GnRH analogue
  • Hyperadrenocorticism

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Deslorelin treatment of hyperoestrogenism in neutered ferrets (Mustela putorius furo) : A case report. / Prohaczik, A.; Kulcsár, M.; Huszenicza, G.

In: Veterinarni Medicina, Vol. 54, No. 2, 02.2009, p. 89-95.

Research output: Contribution to journalArticle

@article{c2dac1a2e45246d9a75e8cb0afb4b161,
title = "Deslorelin treatment of hyperoestrogenism in neutered ferrets (Mustela putorius furo): A case report",
abstract = "Hyperoestrogenism causing progressive alopecia in neutered ferrets may be induced by ovarian remnant syndrome (ORS) and nodular hyperplasia of the adrenocortex (hyperadrenocorticism, NHA). The objective of the study was to determine whether a slow-release implant of a gonadotropin releasing hormone (GnRH) analogue, deslorelin, has any value in therapy of hyperoestrogenism of adrenocortical origin (NHA). Three supposed cases of NHA with alopecia and other clinical signs of hyperoestrogenism (n = 2 spayed females in oestrous and n = 1 castrated male) were treated with a subcutaneous implant of 4.7 mg deslorelin acetate. Blood samples were collected, and plasma levels of estradiol (E2) were determined just before, and some weeks after treatment. For realistic monitoring, blood samples for E2 determination were also taken from intact, healthy (untreated control) females after the beginning of heat (n = 5), or 9-21 days after, with hCG induced ovulation (n = 6), or out of breeding season (n = 3). Before treatment, all three alopecic ferrets showed elevated E2 concentrations (99.45-139.9 pmol/l) similar to the untreated control females in oestrous (61.6-123.02 pmol/l) (P = 0.229). Some weeks after the deslorelin administration, the hair of these ferrets began to grow again and the elevated E2 concentrations significantly decreased compared to the pre-treatment values (P = 0.035). E2 concentrations reached the basal level (12.89-16.08 pmol/l) typical for that of the untreated control females in anoestrus or in luteal phase (12.0-30.58 pmol/l) (P = 0.137). All treated ferrets were examined again 19-21 months after implant insertion (the implant still being present) and all of them had normal hair and were clinically healthy. These observations prove that deslorelin can suppress the E2 production of NHA, and is therefore a useful tool in the therapy of hormonal alopecia neutered ferrets.",
keywords = "Deslorelin, Estradiol, GnRH analogue, Hyperadrenocorticism",
author = "A. Prohaczik and M. Kulcs{\'a}r and G. Huszenicza",
year = "2009",
month = "2",
language = "English",
volume = "54",
pages = "89--95",
journal = "Veterinarni Medicina",
issn = "0375-8427",
publisher = "Institute of Agricultural and Food Information",
number = "2",

}

TY - JOUR

T1 - Deslorelin treatment of hyperoestrogenism in neutered ferrets (Mustela putorius furo)

T2 - A case report

AU - Prohaczik, A.

AU - Kulcsár, M.

AU - Huszenicza, G.

PY - 2009/2

Y1 - 2009/2

N2 - Hyperoestrogenism causing progressive alopecia in neutered ferrets may be induced by ovarian remnant syndrome (ORS) and nodular hyperplasia of the adrenocortex (hyperadrenocorticism, NHA). The objective of the study was to determine whether a slow-release implant of a gonadotropin releasing hormone (GnRH) analogue, deslorelin, has any value in therapy of hyperoestrogenism of adrenocortical origin (NHA). Three supposed cases of NHA with alopecia and other clinical signs of hyperoestrogenism (n = 2 spayed females in oestrous and n = 1 castrated male) were treated with a subcutaneous implant of 4.7 mg deslorelin acetate. Blood samples were collected, and plasma levels of estradiol (E2) were determined just before, and some weeks after treatment. For realistic monitoring, blood samples for E2 determination were also taken from intact, healthy (untreated control) females after the beginning of heat (n = 5), or 9-21 days after, with hCG induced ovulation (n = 6), or out of breeding season (n = 3). Before treatment, all three alopecic ferrets showed elevated E2 concentrations (99.45-139.9 pmol/l) similar to the untreated control females in oestrous (61.6-123.02 pmol/l) (P = 0.229). Some weeks after the deslorelin administration, the hair of these ferrets began to grow again and the elevated E2 concentrations significantly decreased compared to the pre-treatment values (P = 0.035). E2 concentrations reached the basal level (12.89-16.08 pmol/l) typical for that of the untreated control females in anoestrus or in luteal phase (12.0-30.58 pmol/l) (P = 0.137). All treated ferrets were examined again 19-21 months after implant insertion (the implant still being present) and all of them had normal hair and were clinically healthy. These observations prove that deslorelin can suppress the E2 production of NHA, and is therefore a useful tool in the therapy of hormonal alopecia neutered ferrets.

AB - Hyperoestrogenism causing progressive alopecia in neutered ferrets may be induced by ovarian remnant syndrome (ORS) and nodular hyperplasia of the adrenocortex (hyperadrenocorticism, NHA). The objective of the study was to determine whether a slow-release implant of a gonadotropin releasing hormone (GnRH) analogue, deslorelin, has any value in therapy of hyperoestrogenism of adrenocortical origin (NHA). Three supposed cases of NHA with alopecia and other clinical signs of hyperoestrogenism (n = 2 spayed females in oestrous and n = 1 castrated male) were treated with a subcutaneous implant of 4.7 mg deslorelin acetate. Blood samples were collected, and plasma levels of estradiol (E2) were determined just before, and some weeks after treatment. For realistic monitoring, blood samples for E2 determination were also taken from intact, healthy (untreated control) females after the beginning of heat (n = 5), or 9-21 days after, with hCG induced ovulation (n = 6), or out of breeding season (n = 3). Before treatment, all three alopecic ferrets showed elevated E2 concentrations (99.45-139.9 pmol/l) similar to the untreated control females in oestrous (61.6-123.02 pmol/l) (P = 0.229). Some weeks after the deslorelin administration, the hair of these ferrets began to grow again and the elevated E2 concentrations significantly decreased compared to the pre-treatment values (P = 0.035). E2 concentrations reached the basal level (12.89-16.08 pmol/l) typical for that of the untreated control females in anoestrus or in luteal phase (12.0-30.58 pmol/l) (P = 0.137). All treated ferrets were examined again 19-21 months after implant insertion (the implant still being present) and all of them had normal hair and were clinically healthy. These observations prove that deslorelin can suppress the E2 production of NHA, and is therefore a useful tool in the therapy of hormonal alopecia neutered ferrets.

KW - Deslorelin

KW - Estradiol

KW - GnRH analogue

KW - Hyperadrenocorticism

UR - http://www.scopus.com/inward/record.url?scp=67650173383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650173383&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:67650173383

VL - 54

SP - 89

EP - 95

JO - Veterinarni Medicina

JF - Veterinarni Medicina

SN - 0375-8427

IS - 2

ER -